Productizing Nano-Bioactive Glass-Based Bilayer Scaffolds: A Graft for Reconstruction of Mandibular and Femoral Bone Defects.

This investigation aimed to construct a bilayer scaffold integrating alginate and gelatin with nanobioactive glass (BG), recognized for their efficacy in tissue regeneration and drug delivery. Scaffolds, namely, alginate/gelatin (AG), alginate-/actonel gelatin (AGD), alginate actenol/gelatin-45S5 BG (4AGD), and alginate-actonel/gelatin-59S BG (5AGD), were assembled using a cost-effective freeze-drying method, followed by detailed structural investigation via powder X-ray diffraction as well as morphological characterization using field emission scanning electron microscopy (FESEM). FESEM revealed a honeycomb-like morphology with distinct pore sizes for nutrient, oxygen, and drug transport. The scaffolds evidently exhibited hemocompatibility, high porosity, good swelling capacity, and biodegradability. In vitro studies demonstrated sustained drug release, particularly for scaffolds containing actonel. In vivo tests showed that the bilayer scaffold promoted new bone formation, surpassing the control group in bone area increase. The interaction of the scaffold with collagen and released ions improved the osteoblastic function and bone volume fraction. The findings suggest that this bilayer scaffold could be beneficial for treating critical-sized bone defects, especially in the mandibular and femoral regions.

Influence of varying thermal treatment on bioactive material with equal Ca/P ratio: A local drug delivery system for bone regeneration.

Designing a biomaterial with excellent bioactivity, biocompatibility, mechanical strength, porosity, and osteogenic properties is essential to incorporate therapeutic agents in order to promote efficient bone regeneration. The work intended to prepare bioactive glass with tailor-made equal Ca/P (CP) ratio to obtain clinophosinaite (Cpt) as dominant phase. Clinophosinaite (Na3 CaPSiO7 ) is one of the rarest phases of bioactive glass (BG), which is supposed to play key role in bioactivity. The novelty of this work is to track the required sintering temperature to attain equimolar calcium phosphate-containing clinophosinaite phase and its behavior. Further, its consequent physicochemical and biological properties were analyzed. Phase transition from Rhenanite to Cpt, and later the Cpt emerged as dominant phase with increase of calcination temperature from 700 to 1000°C was studied. The quantifying evolution of Cpt with Rhenanite over increasing annealing temperature also results with the major morphological modifications. BET analysis confirmed the surface area and porosity (Type-IV mesoporous) were gradually elevated upto 900°C, which had contrary effect on mechanical strength. Formation of hydroxyl carbonate apatite (HCA) layer confirmed the bioactivity of the prepared samples at varying time intervals. The CP samples demonstrated better hemocompatibility in post-immersion (i.e., less than 1% of lysis) when compared with pre-immersion. Enhanced protein adsorption and cumulative release (85%) of Simvastatin (SIM) drug was attained at 900°C treatment.

Unscrambling the Influence of Sodium Cation on the Structure, Bioactivity, and Erythrocyte Compatibility of 45S5 Bioactive Glass.

The 45S5 bioglass uttering Class A bioactivity promotes both osteoconduction as well as osteoinduction. Though one of the higher reactive bioactive materials known with structural and physiological influence upon ionic modulation, poor mechanical properties are perceived. The possible solution to overcome the weak stability is to choose material's composition that provides retained bioactivity and improved mechanical stability. Meanwhile, primary burst out of Na+ ions increases the local pH, harms cell life, and acts as a well-known disruptive modifying species that weakens the bioactive glass network, decreasing network connectivity, showing faster degradation and lowering mechanical stability. Therefore, in this study, more detailed systematic exploration on structural influence of sodium monovalent cation and its behavior on physiological environment was genuinely studied and reported that bioactivity of the bioactive glass can be highly achieved even without Na+ ions. The result exhibits benefits of sodium free bioactive glass (denoted as No Na+ BG) over Na+ BG and exhibits improved mechanical stability and also possible degradability, having in-built apatite phase even before immersion in simulated body fluid (SBF). Also, sodium free bioglass proved as a superior candidate for erythrocyte compatibility with rapid clotting tendency on interaction with blood and a promising replacement for 45S5 bioglass in all aspects especially in mechanical stability view, which can withstand more than 5 months in phosphate buffer saline (PBS).